EPISODE · Jul 7, 2022 · 17 MIN
A Risk Stratification Model for Low Stage Uterine leiomyosarcoma
from Springer Nature · host Springer Nature
Uterine leiomyosarcoma is the most common uterine mesenchymal malignancy. The majority present at stage I with variable clinical outcome. In this episode of ModPath Chat, Dr. David Chapel discusses his recently published multi-institutional study proposing a novel risk stratification model (shown below) for low stage uterine leiomyosarcoma. Risk score = (coagulative necrosis)(1) + (mitoses > 25 per 2.4mm2)(2) + (atypical mitoses)(2) + (lymphovascular invasion)(3) + (serosal abutment)(5)
Embed this episode
NOW PLAYING
A Risk Stratification Model for Low Stage Uterine leiomyosarcoma
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.